BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3098238)

  • 1. Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect.
    Wallin R
    Biochem J; 1986 Jun; 236(3):685-93. PubMed ID: 3098238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF; Suttie JW
    Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Methylcholanthrene induction of enzymes in the vitamin K-dependent carboxylation system.
    Wallin R; Patrick SD; Martin LF
    Biochem Pharmacol; 1987 Dec; 36(24):4303-6. PubMed ID: 3120735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.
    Wallin R; Martin LF
    J Clin Invest; 1985 Nov; 76(5):1879-84. PubMed ID: 3932474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K antagonism of coumarin intoxication in the rat.
    Wallin R; Patrick SD; Ballard JO
    Thromb Haemost; 1986 Apr; 55(2):235-9. PubMed ID: 2424118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K-dependent carboxylation in the developing rat: evidence for a similar mechanism of action of warfarin in fetal and adult livers.
    Wallin R
    Pediatr Res; 1989 Oct; 26(4):370-6. PubMed ID: 2508052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by warfarin of liver microsomal vitamin K-reductase in warfarin-resistant and susceptible rats.
    MacNicoll AD; Nadian AK; Townsend MG
    Biochem Pharmacol; 1984 Apr; 33(8):1331-6. PubMed ID: 6712738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vivo effects of acenocoumarol, phenprocoumon and warfarin on vitamin K epoxide reductase and vitamin K-dependent carboxylase in various tissues of the rat.
    de Boer-van den Berg MA; Thijssen HH; Vermeer C
    Biochim Biophys Acta; 1986 Oct; 884(1):150-7. PubMed ID: 3490277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lapachol inhibition of DT-diaphorase (NAD(P)H:quinone dehydrogenase).
    Preusch PC
    Biochem Biophys Res Commun; 1986 Jun; 137(2):781-7. PubMed ID: 3089219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of ticrynafen potentiation of coumarin anticoagulant action.
    Preusch PC; Suttie JW
    Biochem Pharmacol; 1983 Aug; 32(16):2393-8. PubMed ID: 6615542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K-dependent carboxylation. Evidence that at least two microsomal dehydrogenases reduce vitamin K1 to support carboxylation.
    Wallin R; Hutson S
    J Biol Chem; 1982 Feb; 257(4):1583-6. PubMed ID: 6799508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K-dependent carboxylation and vitamin K epoxidation. Evidence that the warfarin-sensitive microsomal NAD(P)H dehydrogenase reduces vitamin K1 in these reactions.
    Wallin R; Suttie JW
    Biochem J; 1981 Mar; 194(3):983-8. PubMed ID: 7306037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
    Preusch PC; Suttie JW
    Arch Biochem Biophys; 1984 Nov; 234(2):405-12. PubMed ID: 6497379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity.
    Thijssen HH; Baars LG; Vervoort-Peters HT
    Br J Pharmacol; 1988 Nov; 95(3):675-82. PubMed ID: 3207986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between vitamin K-dependent carboxylase from normal and warfarin-treated cows.
    Vermeer C; Soute BA; De Metz M; Hemker HC
    Biochim Biophys Acta; 1982 Feb; 714(2):361-5. PubMed ID: 6799008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enzymology of doxorubicin quinone reduction in tumour tissue.
    Cummings J; Allan L; Willmott N; Riley R; Workman P; Smyth JF
    Biochem Pharmacol; 1992 Dec; 44(11):2175-83. PubMed ID: 1472082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.
    Thijssen HH; Janssen YP; Vervoort LT
    Biochem J; 1994 Jan; 297 ( Pt 2)(Pt 2):277-80. PubMed ID: 8297331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
    Fasco MJ; Principe LM
    J Biol Chem; 1982 May; 257(9):4894-901. PubMed ID: 7068669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic and molecular aspects of the antioxidant effect of menadione in hepatic microsomes.
    Tampo Y; Yonaha M
    Arch Biochem Biophys; 1996 Oct; 334(1):163-74. PubMed ID: 8837752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K1 hydroquinone formation catalyzed by DT-diaphorase.
    Fasco MJ; Principe LM
    Biochem Biophys Res Commun; 1982 Jan; 104(1):187-92. PubMed ID: 6803779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.